How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r

Updated on: January 02,2024

How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r

Updated on:January 02,2024

Research team discovers a connection between nutrients and follicular lymphoma

by The Spanish National Cancer Research CentreOn the left, follicular lymphoma in a mouse model with abundant multiplying B cells dyed brown. On the right, inhibition of this multiplication using

Updated on: May 27,2024

Research team discovers a connection between nutrients and follicular lymphoma

by The Spanish National Cancer Research CentreOn the left, follicular lymphoma in a mouse model with abundant multiplying B cells dyed brown. On the right, inhibition of this multiplication using

Updated on:May 27,2024

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo

Updated on: March 06,2024

Shorter drug treatment OK for many breast cancer patients

by Marilynn MarchioneThis undated image made available by F. Hoffmann-La Roche shows a vial of the company's Herceptin medication. According to a study released on Wednesday, May 16, 2018, many wo

Updated on:March 06,2024

Cancer drug restores immune system's ability to fight tumors

by University of Texas at AustinCredit: Pixabay/CC0 Public DomainA new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The Universit

Updated on: March 06,2024

Cancer drug restores immune system's ability to fight tumors

by University of Texas at AustinCredit: Pixabay/CC0 Public DomainA new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The Universit

Updated on:March 06,2024

Study identifies how cancer-causing gene regulates genetic variation in prostate cancer

by Queen Mary, University of LondonGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111404Researchers from Barts Cancer Institute (BCI) at Queen Mary Universi

Updated on: January 30,2024

Study identifies how cancer-causing gene regulates genetic variation in prostate cancer

by Queen Mary, University of LondonGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111404Researchers from Barts Cancer Institute (BCI) at Queen Mary Universi

Updated on:January 30,2024

Proximity to muscle cells may promote spread of prostate cancer cells, NIH study suggests

by National Institutes of HealthFrom left to right: prostate cancer cells (square) near skeletal (oblong) and smooth (oval) muscle cells respond to Interleukins 4 and 13 (IL4/13) by producing ann

Updated on: March 08,2024

Proximity to muscle cells may promote spread of prostate cancer cells, NIH study suggests

by National Institutes of HealthFrom left to right: prostate cancer cells (square) near skeletal (oblong) and smooth (oval) muscle cells respond to Interleukins 4 and 13 (IL4/13) by producing ann

Updated on:March 08,2024

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on: February 03,2024

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on:February 03,2024

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on: December 28,2023

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January

Updated on:December 28,2023

Research extends hope for gastric cancer patients with peritoneal metastasis

byDuke-NUS Medical SchoolProfessor Jimmy So, National University Cancer Institute, Singapore; Dr Yong Wei Peng, National University Cancer Institute, Singapore; Dr Raghav Sundar, National Univer

Updated on: September 30,2024

Research extends hope for gastric cancer patients with peritoneal metastasis

byDuke-NUS Medical SchoolProfessor Jimmy So, National University Cancer Institute, Singapore; Dr Yong Wei Peng, National University Cancer Institute, Singapore; Dr Raghav Sundar, National Univer

Updated on:September 30,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on: March 30,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on:March 30,2024

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on: February 18,2024

Researchers design 'prodrug' that targets cancer cells' big appetite for glutamine, leaving healthy cells unharmed

by Johns Hopkins University School of MedicineSchematic showing DRP-104's bio-activation to DON in tumor and bio-inactivation to an inert metabolite in GI tissues. Credit: Jennifer E. Fairman

Updated on:February 18,2024

Preclinical characterization of therapeutic antibodies

by Rapamycin PressSchematic of experimental procedures for generation of novel anti-Sonic Hedgehog (Shh) candidate therapeutic antibodies directed at the carboxy (C)-terminal. (A) Two synthetic peptid

Updated on: March 12,2024

Preclinical characterization of therapeutic antibodies

by Rapamycin PressSchematic of experimental procedures for generation of novel anti-Sonic Hedgehog (Shh) candidate therapeutic antibodies directed at the carboxy (C)-terminal. (A) Two synthetic peptid

Updated on:March 12,2024